SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

PAPI, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 43.195
AS - Asia 25.223
EU - Europa 13.489
SA - Sud America 4.276
AF - Africa 631
OC - Oceania 187
Continente sconosciuto - Info sul continente non disponibili 25
Totale 87.026
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 42.223
SG - Singapore 9.176
CN - Cina 5.256
IT - Italia 3.303
BR - Brasile 3.275
VN - Vietnam 2.704
HK - Hong Kong 2.373
DE - Germania 1.894
UA - Ucraina 1.886
BD - Bangladesh 1.458
FI - Finlandia 1.325
GB - Regno Unito 1.238
TR - Turchia 1.185
FR - Francia 852
NL - Olanda 740
JP - Giappone 732
RU - Federazione Russa 643
SE - Svezia 539
IN - India 537
ID - Indonesia 525
CA - Canada 406
MX - Messico 398
AR - Argentina 370
PL - Polonia 286
IQ - Iraq 195
ZA - Sudafrica 184
AU - Australia 165
PK - Pakistan 156
EC - Ecuador 155
ES - Italia 142
CO - Colombia 129
AT - Austria 122
PH - Filippine 117
MA - Marocco 94
MY - Malesia 89
VE - Venezuela 89
SA - Arabia Saudita 85
PY - Paraguay 83
KR - Corea 79
BE - Belgio 77
UZ - Uzbekistan 76
EG - Egitto 70
LT - Lituania 70
TN - Tunisia 66
TW - Taiwan 66
CL - Cile 65
AE - Emirati Arabi Uniti 63
KE - Kenya 59
PE - Perù 52
CZ - Repubblica Ceca 51
CH - Svizzera 42
TH - Thailandia 42
DZ - Algeria 41
IE - Irlanda 41
UY - Uruguay 31
JO - Giordania 30
NP - Nepal 30
JM - Giamaica 29
KZ - Kazakistan 28
LB - Libano 26
PT - Portogallo 26
RO - Romania 26
AL - Albania 25
AZ - Azerbaigian 24
GT - Guatemala 24
IL - Israele 23
BO - Bolivia 22
GR - Grecia 22
IR - Iran 21
NZ - Nuova Zelanda 20
ET - Etiopia 19
CR - Costa Rica 18
PS - Palestinian Territory 18
DO - Repubblica Dominicana 16
HN - Honduras 16
HR - Croazia 16
RS - Serbia 15
BG - Bulgaria 14
EU - Europa 13
GE - Georgia 13
NG - Nigeria 12
PA - Panama 12
SV - El Salvador 12
BH - Bahrain 11
MK - Macedonia 11
OM - Oman 11
DK - Danimarca 10
HU - Ungheria 10
NI - Nicaragua 10
SN - Senegal 10
SY - Repubblica araba siriana 10
MD - Moldavia 9
SI - Slovenia 9
XK - ???statistics.table.value.countryCode.XK??? 9
KH - Cambogia 8
MN - Mongolia 8
TT - Trinidad e Tobago 8
VI - Stati Uniti Isole Vergini 8
AO - Angola 7
BY - Bielorussia 7
Totale 86.846
Salva come PNG Salva come JPEG
Città #
Singapore 5.607
Ashburn 5.032
Fairfield 4.048
Woodbridge 3.629
Houston 2.648
San Jose 2.499
Hong Kong 2.328
Jacksonville 2.044
Santa Clara 1.699
Chandler 1.631
Seattle 1.539
Wilmington 1.436
Ann Arbor 1.327
Beijing 1.326
Cambridge 1.319
Dallas 1.319
Ho Chi Minh City 889
New York 755
Helsinki 732
Los Angeles 719
Izmir 702
Tokyo 688
Nanjing 639
Hanoi 631
Council Bluffs 597
Princeton 564
Lauterbourg 549
Munich 520
Milan 413
Jakarta 374
San Diego 374
Ferrara 348
Boardman 315
São Paulo 279
Chicago 263
Warsaw 249
Mexico City 248
Washington 246
Shanghai 217
Buffalo 215
Rome 201
Nanchang 196
Tianjin 178
Shenyang 173
London 166
Hefei 155
Moscow 143
Frankfurt am Main 142
Orem 136
Addison 131
Da Nang 130
Hebei 124
Toronto 119
Changsha 116
Lappeenranta 116
Dearborn 110
Nuremberg 108
Haiphong 103
Rio de Janeiro 103
Jiaxing 102
Naples 98
Bologna 96
Montreal 93
Turku 93
Atlanta 91
Brooklyn 90
Denver 90
Dong Ket 90
Mountain View 87
Guangzhou 84
The Dalles 81
Chennai 80
Falls Church 80
Baghdad 78
Boston 77
Falkenstein 76
Phoenix 76
Redwood City 74
San Francisco 71
Zhengzhou 70
Norwalk 66
Tashkent 66
Belo Horizonte 65
Johannesburg 65
Stockholm 61
Vienna 61
Amsterdam 60
Curitiba 60
Manchester 58
Mumbai 57
Quito 55
Jinan 54
Sydney 54
Dhaka 53
Kunming 53
Verona 52
Biên Hòa 50
Brussels 50
Bremen 49
Lahore 48
Totale 56.521
Salva come PNG Salva come JPEG
Nome #
Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program 679
Asthma 522
Asthma death. Part 1: Clinical phenotypes, epidemiology and risk factors 499
Value of fiberoptic bronchoscopy in addition to 18F-FDG-PET/CT in the differentiation of solitary pulmonary nodules: a prospective study 438
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 342
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations 338
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial 323
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 318
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 311
Targeting Th2 cells in asthmatic airways 299
Intravenous N-acetylcysteine in respiratory disease with abnormal mucus secretion 290
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial 288
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 282
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial 274
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 264
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 262
Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS) 260
An official American Thoracic Society/European Respiratory Society statement: research questions in COPD 259
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells 258
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 257
Blood Eosinophils and Chronic Obstructive Pulmonary Disease: A GOLD Science Committee 2022 Review 256
Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study 251
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 250
Primary pulmonary epithelioid hemangioendothelioma: A rare cause of PET-negative pulmonary nodules 247
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 239
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial 239
Emphysema contribution to the progression of chronic obstructive pulmonary disease. 237
Oxygen radical scavengers inhibit clastogenic activity induced by sonication of human serum 235
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma 235
Deficient antiviral immune responses in childhood: Distinct roles of atopy and asthma 233
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 231
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial 227
Bronchopulmonary inflammation and airway smooth muscle hyperresponsiveness induced by nitrogen dioxide in guinea pigs 227
N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses 226
Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma 223
Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients 222
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 220
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 219
A serum proteome signature to predict mortality in severe COVID-19 patients 219
Respiratory Syncytial Virus Infection in Older Adults: An Update 218
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 216
Reducing agents decrease the oxidative burst and improve clinical outcomes in COPD patients: A randomised controlled trial on the effects of sulphurous thermal water inhalation 215
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 215
Extrafine Versus Fine Inhaled Corticosteroids in Relation to Asthma Control: A Systematic Review and Meta-Analysis of Observational Real-Life Studies 215
Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial 213
Malattie polmonari primitive da cause dismetaboliche. 213
Differential expression of RNA-binding proteins in bronchial epithelium of stable COPD patients 213
Effect of subchronic in vivo exposure to nitrogen dioxide on lung tissue inflammation, airway microvascular leakage, and in vitro bronchial muscle responsiveness in rats 212
Severe Pneumonia following intravescical BCG therapy in a patient with bladder cancer. 212
Description of a randomised controlled trial of inhaled corticosteroid/fast-onset LABA reliever therapy in mild asthma 212
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 211
Activation of NF-kappaB transcription factor in asthma death 211
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease 210
Diffuse pulmonary meningothelial like nodules simulating metastatic thymoma 210
Pharmacokinetics and Safety of Single and Multiple Doses of Oral N-Acetylcysteine in Healthy Chinese and Caucasian Volunteers: An Open-Label, Phase I Clinical Study 210
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline 210
Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy 209
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study 209
A randomized, double-blinded, double-dummy efficacy and safety study of budesonide-formoterol Spiromax® compared to budesonide-formoterol Turbuhaler® in adults and adolescents with persistent asthma 206
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up 206
COPD: early diagnosis and treatment to slow disease progression 205
Efficacy of fluticasone propionate/formoterol fumarate in the treatment of asthma: A pooled analysis 205
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial 205
Cellule staminali e patologia polmonare dell’adulto 204
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients 204
A new combination therapy for asthma: bridging the gap between effectiveness in trials and clinical practice? 203
Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells 201
Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes 201
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 201
Natural Killer Cells in SARS-CoV-2-Vaccinated Subjects with Increased Effector Cytotoxic CD56dim Cells and Memory-Like CD57+NKG2C+CD56dim Cells 200
Enfisema polmonare: prospettive di terapia 200
A defective type 1 response to rhinovirus in atopic asthma 199
A Novel Insight into Adaptive Immunity in Chronic Obstructive Pulmonary Disease B Cell Activating Factor Belonging to the Tumor Necrosis Factor Family 199
Asthma management 198
Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations 198
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 198
Interleukin-13 and-4 expression in the central airways of smokers with chronic bronchitis 196
Circulating endothelial stem cells are not decreased in pulmonary emphysema or COPD 196
Phospho-p38 MAPK expression in COPD patients and asthmatics and in challenged bronchial epithelium 196
Apporto esogeno di riducenti e attività del rinovirus HRV16 193
Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells 192
Rhinovirus vaccination: the case against 192
A valid option for asthma control: Clinical evidence on efficacy and safety of fluticasone propionate/formoterol combination in a single inhaler 192
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer 192
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 191
Models of infection and exacerbations in COPD. 190
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics 190
Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease 190
Dual Bronchodilation Response by Exacerbation History and Eosinophilia in the FLAME Study 189
Ectopic thymoma simulating a pericardial cyst: case report 189
Rhinovirus Infection Induces Degradation of Antimicrobial Peptides and Secondary Bacterial Infection in Chronic Obstructive Pulmonary Disease 188
Mechanisms of rhinovirus-induced asthma 186
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease 185
Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study 185
Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma 185
COPD exacerbations: definitions and classifications 184
Association between markers of emphysema and more severe chronic obstructive pulmonary disease 184
An unusual case of congenital short trachea with very long bronchi mimicking bronchial asthma 183
Management of bronchial asthma 182
Right Ventricle Function in Patients with Acute Coronary Syndrome and Concomitant Undiagnosed Chronic Obstructive Pulmonary Disease 182
Totale 23.398
Salva come PNG Salva come JPEG
Categoria #
all - tutte 404.365
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 18.342
Totale 422.707
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021659 0 0 0 0 0 0 0 0 0 0 0 659
2021/20225.146 219 452 320 258 197 236 283 293 204 380 461 1.843
2022/20234.213 575 103 145 491 619 645 179 385 531 65 314 161
2023/20242.742 248 267 113 83 137 279 78 136 88 259 348 706
2024/202511.287 303 293 998 331 1.307 813 351 716 1.934 1.653 1.447 1.141
2025/202638.260 2.708 1.677 3.921 4.392 4.676 2.199 4.067 2.238 3.792 4.235 2.590 1.765
Totale 88.338